VCM
MPLT

Versant Capital Management’s MapLight Therapeutics MPLT Stock Holding History

Versant Capital Management’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Hold
50
– – ﹤0.01% 2573
2026
Q1 		$1.02K Buy
+50
New +$894 ﹤0.01% 2653

Other funds holding MPLT

MSWMA
Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 16.2% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Versant Capital Management's MPLT Position: Q2 2026 in Review

Versant Capital Management held its MapLight Therapeutics (MPLT) position steady in Q2 2026 at 50 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Versant Capital Management first reported a position in MPLT in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • Versant Capital Management held 50 shares of MapLight Therapeutics worth $1.79K as of Q2 2026.
  • Versant Capital Management left its MapLight Therapeutics share count unchanged in Q2 2026.
  • MapLight Therapeutics made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2573 holding.
  • Versant Capital Management first reported a position in MapLight Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.